)
MOHCCN Seminar Series
This seminar series features virtual talks from MOHCCN research partner investigators and trainees, providing a platform for MOHCCN members to share their ongoing work in precision oncology with the wider Network. These seminars will be of interest primarily to cancer researchers, clinicians, trainees, and members of the MOHCCN Patient Working Group across the country.
Upcoming seminars
Next: Thursday, June 19th 2025 - BC Cancer Consortium
11am PT / 12pm MT / 1pm CT / 2pm ET / 3pm AT / 3:30pm NT
REGISTER NOW!
Agenda
Consortium Activities Update
Daniel Renouf, MD, MPH FRCPC - Medical oncologist, BC Cancer; Assistant professor, Medical Oncology, University of British Columbia; MOHCCN consortium lead
Research Presentations
Mechanisms of therapy resistance and relapse in AML
Aly Karsan, MD - Professor, Department of Pathology of Laboratory Medicine, University of British Columbia; Distinguished scientist, Canada's Michael Smith Genome Sciences Centre, BC Cancer; MOHCCN consortium lead
Tracking clonal structure from AML diagnosis to relapse using mitochondrial variants
Derek Tam, MSc - Bioinformatics Graduate Program, University of British Columbia; BC Cancer Research Institute
This event will co-chaired by Dan Murphy, a member of the MOHCCN Patient Working Group, and by Véronique LeBlanc, PhD, Program Manager and Scientific Writer, MOHCCN.